Patents
Patents for C07H 15 - Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals (17,975)
06/2005
06/22/2005CN1207268C Novel derivatives of 3-3-diphenylpropylamines
06/21/2005US6908989 Process for the production of perbenzylated 1-O-glycosides
06/16/2005WO2005054264A2 Glycomimetic antagonists for both e- and p-selectins
06/16/2005WO2005033652A3 Methods for comparing relative flux rates of two or more biological molecules in vivo through a single protocol
06/16/2005US20050130908 Treatment or amelioration of depression; provides better bioavailability
06/16/2005CA2546784A1 Glycomimetic antagonists for both e- and p-selectins
06/15/2005EP1541580A1 Sulfotransferase inhibitors
06/15/2005EP1541579A1 Produrg, medicinal utilization thereof and process for producing the same
06/15/2005EP1541578A1 Process for selective production of aryl 5-thio-beta-d-aldohexopyranosides
06/15/2005EP1539780A1 Derivatives of monosaccharides for drug discovery
06/15/2005EP1539779A2 Condensed palatinose in hydrogenated form
06/15/2005EP1177273B1 Highly concentrated free-flowing pearly lustre concentrates
06/15/2005CN1626542A Method for preparing vancomycin of norhydrochloric acid
06/14/2005US6906230 Method for producing alcohol surfactants and alcohol ether surfactants, the products obtained and their use
06/14/2005US6906175 Production of adenine nucleotide translocator (ANT), novel ANT ligands and screening assays therefor.
06/14/2005US6906174 Production of adenine nucleotide translocator (ANT), novel ANT ligands and screening assays therefor
06/09/2005WO2005051969A1 Novel analgesic compounds, extracts containing same and methods of preparation
06/09/2005WO2005051920A2 Specific antagonist for both e- and p-selectins
06/09/2005WO2005021497A3 Tethered dimers and trimers of 1,4-diphenylazetidn-2-ones
06/09/2005WO2005003777A3 Enzyme-catalyzed metal deposition for the enhanced in situ detection of immunohistochemical epitopes and nucleic acid sequences
06/09/2005US20050124563 Triazole linked carbohydrates
06/09/2005US20050124556 an indoxyl beta-D-ribofuranoside chromogenic substrate for detecting beta-D-ribofuranosidase activity; synthesis by r3eacting a ribofuranosyl trichloroacetimidate with an N-protected 3-hydroxyindole compound
06/09/2005US20050123599 Oil-in-water adjuvant of water, MF59, a steroid and a saponin; vaccine
06/09/2005US20050123533 Prodrugs activated by targeted catalytic proteins
06/09/2005CA2547311A1 Novel analgesic compounds, extracts containing same and methods of preparation
06/08/2005EP1538156A1 Versatile linker compound and ligand, and method for preparation thereof
06/08/2005EP1537131A1 Antimicrobial molecule
06/08/2005EP1536793A1 Pharmaceutical compositions comprising fk506 derivatives and the ir use for the treatment of allergic diseases
06/08/2005EP1465854A4 Chalcone derivatives and their use to treat diseases
06/08/2005EP1299109A4 Bifunctional antibiotics
06/08/2005EP1252133B1 Pharmaceutical compounds
06/08/2005EP1001797B1 Soya extract, process for its preparation and pharmaceutical composition
06/08/2005CN1625559A Novel compounds that inhibit factor Xa activity
06/08/2005CN1623997A Method for preparing alkyl glucoside
06/08/2005CN1205217C Oligosaccharides derived from ribose-ribitol-phosphate, and vaccines containing them
06/07/2005US6903076 Antihelminthic anthraquinones and method of use thereof
06/07/2005US6902908 Polypeptides, fusion proteins; includes production and use recombinant expression constructs having regulated promoter; mitochondria
06/07/2005CA2225439C Propiophenone derivatives and process for preparing the same
06/02/2005WO2005049631A1 Synthetic molecules having immune activity
06/02/2005WO2005049598A1 Colouring hydrosoluble yellow preparation derived from dihydrochalcones
06/02/2005WO2005048921A2 Bicyclic carbohydrates for the treatment of infections caused by the alphaherpesvirinae hsv-1 and hsv-2
06/02/2005US20050119192 Crystals of glucopyranosyloxybenzyl benzene derivative
06/02/2005US20050118316 Maltitol crystals containing crystal of saccharide except maltitol and method for production thereof
06/01/2005EP1535891A1 Remedy
06/01/2005EP1534725A2 Compounds and methods for inhibiting selectin-mediated function
06/01/2005EP1248761A4 Compounds which mimic the chemical and biological properties of discodermolide
06/01/2005CN1622812A Prophylactic and therapeutic treatment of infectious and other diseases with immune effect compound
06/01/2005CN1622754A Novel immune effect compound
05/2005
05/31/2005US6900182 Inositolphosphoglycan and ribose for treatment of ischaemia-reperfusion injury
05/26/2005US20050113315 Such as methyl-4-(2-hydroxybenzyl)benzoate for treatment/prevention of diabetes, diabetic complications, and/or obesity; sodium glucose transport protein inhibitors
05/25/2005EP1531854A2 O-derivatized nocathiacin derivatives
05/25/2005EP1372670B1 Caloporoside derivatives, methods for the production thereof and their use
05/25/2005CN1618322A Method for producing tablet, baked product or chewing gum
05/24/2005US6897198 Method of treatment with combinations of statin and aryl-substituted propanolamine derivatives
05/24/2005CA2109259C Prodrugs, their preparation and use as pharmaceuticals
05/19/2005WO2005044256A1 2-azetidinones as anti-hypercholesterolemic agents
05/19/2005US20050107311 buffalo milk and human milk have comparable GM1 and polysialo-ganglioside levels; infant formula; pet foods; instant milk
05/19/2005DE4444606B4 Verfahren zur Herstellung der Sennoside A und B Process for the preparation of sennosides A and B.
05/19/2005CA2543943A1 2-azetidinones as anti-hypercholesterolemic agents
05/18/2005EP1531158A1 Lipid A and topic, in particular cosmetic, composition thereof
05/18/2005EP1224195B1 C-aryl glucoside sglt2 inhibitors
05/18/2005CN1616474A Acetamido glucose devicative of indomethacin and its synthetic method and use
05/18/2005CN1202115C Preparing method for neamine
05/18/2005CN1201741C Preventives and remedies for ischemic reflow disorder
05/17/2005US6894160 Converting sugars such as glucose and fructose into industrial useful products via hydrogenation and reductive amination using platinum catalyst formed from stabilized nanoparticles
05/17/2005US6894046 For treating eosinophil-dependent inflammatory diseases, asthma
05/17/2005US6894034 Sebum production inhibitors
05/17/2005CA2316217C Lower alkyl alcohol recovery from a stripping mixture
05/12/2005WO2005042553A1 Method for the direct synthesis of oligorhamnosides, composition comprising oligorhamnosides and use thereof as a medicament
05/12/2005WO2005042539A1 Tocopherol-modified therapeutic drug compounds
05/12/2005WO2005041983A1 Medicament comprising a reducing alkyl-sugar monomer for the treatment of inflammatory disorders
05/12/2005US20050101775 Cyclic phosph(oramid)ate prodrugs having alcohol, amine, orthiol groups attached to phosphorus; camptothecins; pharmacodynamic half-life; diagnostic imaging
05/12/2005US20050100976 Enzyme-catalyzed metal deposition for the enhanced detection of analytes of interest
05/12/2005US20050100611 Administering a therapeutically effective amount of arsenic compounds, optionally along with other non-arsenic therapeutic agents, to a mammal for treating solid tumors
05/12/2005US20050100534 firoin and firoin-A from extremophilic microorganisms ; active protection and stabilization of skin cells and their organic constituents (proteins, enzymes, membranes, nucleic acids or antioxidants); against damaging environmental influences, UV radiation.
05/12/2005CA2726967A1 Hydrochloride salts of a glycopeptide phosphonate derivative
05/12/2005CA2544361A1 Method for the direct synthesis of oligorhamnosides, composition comprising oligorhamnosides and use thereof as a medicament
05/12/2005CA2544107A1 Medicament comprising a reducing alkyl-sugar monomer for the treatment of inflammatory disorders
05/11/2005EP1529052A2 Lincomycin derivatives possessing antibacterial activity
05/11/2005CN1615153A Drug for preventing vascular restenosis and instrument to be embedded in vessel coated with the drug
05/11/2005CN1613862A Adriacin derivative with anti-cancer activity
05/11/2005CN1200945C Process for acylation of amino alcohols
05/11/2005CN1200704C Appliance of probucol monoesters for treatment of cardiovascular and inflammatory disease
05/10/2005US6890559 Directly compressible raw material for tablets
05/06/2005WO2004080960A3 Methods and compositions for the enzymatic synthesis of gangliosides
05/05/2005US20050096340 lipophilic derivatives of paclitaxel, camptothecin, docetaxel or derivatives thereof; tocopherol succinate paclitaxel for example; emulsions for drug delivery, treating cancer; increased plasma elimination half-life compared to the parent therapeutic drug
05/04/2005EP1528066A1 Aryl 5-thio-d-glucopyranoside derivatives and remedies for diabetes containing the same
05/04/2005EP1527783A1 Iridoid-saccharide compound and method of using same
05/04/2005EP1527081A1 Glyconjugates comprising carbohydrate epitopes, methods for theirsynthesis, and their use for the treatment or prophylaxis of cancer
05/04/2005EP1526862A1 Simmondsin for use as an angiogenesis inhibitor
05/04/2005EP1526828A2 Cosmetic preparations with antibacterial properties
05/04/2005EP1397376B1 Method for producing perbenzylated 1-o-glycosides
05/04/2005CN1611508A Process for preparing salicin
05/04/2005CN1200003C Synthetic polysaccharides, preparation method therefor and pharmaceutical compositions containing same
05/04/2005CN1199980C Method for microwave extracting nimbin from nim kernal
05/04/2005CN1199979C Water-soluble safflower extract and its oral preparation for treating and preventing angiocardiopathy and cerebrovascular disease
05/04/2005CN1199932C Trijunganone and its derivative, and its preparing process and application
05/04/2005CN1199695C Composition with carbohydrate matrix contaniing liposoluble substance
05/03/2005US6887854 Absorption, fluorescence; using light for optical medical diagnosis
05/03/2005US6887670 For drug screening; solid phase synthesis; fusion proteins; genetic engineering
1 ... 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 ... 180